NHS Pharmaceuticals 2017_2
NHS Pharmaceuticals 2017_2. Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months. Potential periods of call-offs under the framework agreement: CESW regions: 1.8.2018 to 28.2.2019 (7 months). NWLN regions: 1.8.2018 to 31.7.2019 (12 months). LSNE regions: 1.8.2018 to 31.1.2020 (18 months). Products on the framework include (but are not necessarily limited to): Abacavir, Abiraterone, Anidulafungin, Atovaquone, Bosentan, Ciclesonide, Drospirenone/Ethinylestr...
Buyer
NHS England
Value
£22,630,855
Published
21 May 2018
Closes
26 Jan 2018
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
31 Jul 2018
Contract ends
31 Jan 2020
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS Pharmaceuticals 2017_2
£22,630,855
NHS Pharmaceuticals 2017_2. Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months. Potential periods of call-offs under the framework agreement: CESW regions: 1.8.2018 to 28.2.2019 (7 months). NWLN regions: 1.8.2018 to 31.7.2019 (12 months). LSNE regions: 1.8.2018 to 31.1.2020 (18 months). Products...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Guernsey, Isle of Man, Jersey, London · United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
21 May 2018
Awarded contract notice on Contracts Finder
Award notice · Web page
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · PDF
Link to e-sourcing portal
Not provided
Link to e-sourcing portal
Tender notice
Contains public sector information licensed under the Open Government Licence v3.0.